SSB 5236
In CommitteeSenate
Anesthetics/greenhouse gases
Concerning emissions of greenhouse gases used for anesthetic purposes.
This status may be delayed. See Action History below for the latest updates.
How does a bill become law?
- Introduced: The bill is filed and assigned a number.
- Committee: A subject-matter committee holds hearings, takes public testimony, and decides whether to advance the bill.
- Floor Vote: The full chamber (House or Senate) debates and votes on the bill.
- Opposite Chamber: The bill repeats the committee and floor vote process in the other chamber.
- Governor: The Governor reviews the bill and decides whether to sign or veto it.
- Signed: The bill has been signed into law.
AI Analysis
This bill directs Washington’s Department of Ecology to study emissions from medical, dental, and veterinary anesthetic gases—which are potent greenhouse gases—and develop non-binding guidance to reduce those emissions. It does not ban any gases outright but sets a framework for future legislative action and encourages voluntary reductions while protecting patient care and professional judgment.
- The legislature directs the Department of Ecology to study emissions from anesthetic gases (e.g., desflurane, isoflurane, sevoflurane, halothane, and nitrous oxide) and recommend ways to reduce them.
- By October 1, 2026, the Department of Ecology must submit recommendations to the legislature—including possible bans or restrictions on specific anesthetic gases—after consulting with the Department of Health.
- By January 1, 2027, the Department of Ecology must develop a non-binding guidance document to help healthcare facilities reduce emissions from anesthetic gases, with input from professional boards, medical associations, and environmental experts.
- The guidance must prioritize patient safety and professional judgment, and cannot require changes that increase liability or risk for providers or facilities.
- Facilities and practitioners must follow the guidance by January 1, 2028, but no penalties will be issued for noncompliance.
Who is affected
- Healthcare facilities and practitioners (doctors, dentists, veterinarians) — Hospitals, clinics, dental offices, and veterinary practices that use anesthetic gases may need to adjust procedures or adopt new equipment to reduce emissions, though the bill explicitly prohibits penalties for noncompliance with the guidance.
- Medical, dental, and veterinary professional associations and licensing boards — May need to adjust procurement and usage practices for anesthetic gases and may be consulted during guidance development.
- Washington State Department of Ecology — Will lead the study and guidance development process, and must coordinate with other state agencies and stakeholders.
- Washington State Department of Health — Will provide input on health and safety implications and may offer alternative recommendations during the rulemaking process.
Pro/Con Analysis
Stronger case for benefits
Potential Benefits (4)
The bill addresses a currently unregulated source of potent greenhouse gases—nitrous oxide and volatile anesthetics have global warming potentials hundreds to thousands of times higher than CO₂—so even modest reductions yield meaningful climate benefits for Washington’s 2025–2035 emissions targets, especially as healthcare emissions grow with aging population.
EnvironmentPeopleRef: Sec. 1(3)(b); Sec. 3(1)The requirement to consult national medical societies and review existing best practices ensures that any shifts in clinical practice are evidence-based and aligned with professional standards, reducing the risk of unsafe or impractical mandates.
HealthcarePeopleRef: Sec. 3(2)(a)–(c)The explicit prohibition on requiring care that increases liability or clinical risk protects provider autonomy and patient safety—preventing well-intentioned climate goals from overriding clinical judgment in urgent or complex cases.
Rights & LibertiesLean peopleRef: Sec. 3(3)By mandating consultation with UW and WSU and peer-reviewed literature, the bill supports knowledge transfer and may spur curriculum development in environmental health and sustainable clinical practice—benefiting future healthcare workers and public health researchers.
EducationLean peopleRef: Sec. 3(1)
Potential Concerns (3)
Healthcare facilities and practitioners face operational disruption costs (e.g., equipment upgrades, staff retraining, gas substitution) to comply with non-binding guidance, even though no penalties apply—these costs fall disproportionately on small clinics, dental offices, and veterinary practices that lack economies of scale to absorb them.
Business & EmploymentRef: Sec. 3(4)The bill explicitly prioritizes patient safety and professional judgment, but the requirement to consider liability and financial impacts suggests real trade-offs: switching to lower-GWP anesthetics may increase clinical risk or cost in some procedures, potentially limiting access or quality of care—especially in rural or under-resourced facilities.
HealthcarePeopleRef: Sec. 3(2)(d), (e)The bill creates future uncertainty for local governments and publicly funded health systems (e.g., county hospitals, community health centers) by mandating a study and recommendations that may lead to future regulatory or procurement changes—potentially forcing costly shifts in procurement or protocols without guaranteed state funding.
Local GovernmentPeopleRef: Sec. 2(2)
Who Is Most Affected
Small clinics, dental offices, and veterinary practices—especially in rural areas—may face disproportionate administrative and procurement costs to adopt lower-GWP alternatives, though they are shielded from penalties. Many lack the capital to invest in scavenging systems or alternative gas infrastructure.
Large hospital systems and health networks have greater resources to absorb transition costs and may benefit from early adoption of sustainability practices that enhance their public image and meet investor ESG criteria—potentially giving them a competitive advantage.
Anesthesiologists and anesthetists may face increased cognitive load in balancing environmental goals with clinical judgment, but national societies already support voluntary reduction efforts—so many may welcome the clarity and professional collaboration.
Environmental advocates see this as a necessary step to close a regulatory gap in Washington’s climate policy, though the non-binding nature limits near-term impact. They may use the guidance as leverage for future legislative action.
The Department of Ecology gains authority to study and report on a previously unregulated emissions source, expanding its climate policy footprint—but the lack of enforcement power limits its immediate regulatory impact.